Found: 13
Select item for more details and to access through your institution.
Two-stage multivariate Mendelian randomization on multiple outcomes with mixed distributions.
- Published in:
- Statistical Methods in Medical Research, 2023, v. 32, n. 8, p. 1543, doi. 10.1177/09622802231181220
- By:
- Publication type:
- Article
Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231183682
- By:
- Publication type:
- Article
Renal artery stenosis: a disease worth pursuing.
- Published in:
- Medical Journal of Australia, 2001, v. 175, n. 3, p. 149, doi. 10.5694/j.1326-5377.2001.tb143064.x
- By:
- Publication type:
- Article
Diabetes and hypertensionAustralian Diabetes Society position statement.
- Published in:
- Medical Journal of Australia, 1995, v. 163, n. 7, p. 372, doi. 10.5694/j.1326-5377.1995.tb124634.x
- By:
- Publication type:
- Article
Clinical and metabolomic characterization of Brivanib‐Induced hypertension in metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 15, p. 16019, doi. 10.1002/cam4.6248
- By:
- Publication type:
- Article
Clustering on longitudinal quality‐of‐life measurements using growth mixture models for clinical prognosis: Implementation on CCTG/AGITG CO.20 trial.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 5, p. 6117, doi. 10.1002/cam4.5341
- By:
- Publication type:
- Article
Fc‐gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 11, p. 5478, doi. 10.1002/cam4.1819
- By:
- Publication type:
- Article
Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 4, p. 457, doi. 10.1016/j.clcc.2023.08.006
- By:
- Publication type:
- Article
Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
The relationship between rash, tumour KRAS mutation status and clinical and quality of life outcomes in patients with advanced colorectal cancer treated with cetuximab in the NCIC CTG/AGITG CO.17.
- Published in:
- Acta Oncologica, 2014, v. 53, n. 7, p. 877, doi. 10.3109/0284186X.2013.879202
- By:
- Publication type:
- Article
Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy- Refractory Metastatic Colorectal Cancer Treated With Cetuximab.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 16, p. 1812, doi. 10.1001/jama.2010.1535
- By:
- Publication type:
- Article
A Bayesian approach for two‐stage multivariate Mendelian randomization with mixed outcomes.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 13, p. 2241, doi. 10.1002/sim.9721
- By:
- Publication type:
- Article